Departure Of Cfo (new) — Chief Financial Officer resigned effective June 5, 2026, with no external replacement announced.
Nasdaq Compliance Deficiency (new) — Company violated Nasdaq listing rules due to board vacancies and is not eligible for standard cure periods.

NASDAQ: TPST Tempest Therapeutics, Inc. 8-K

Tempest CFO resigns; company scrambles to fix Nasdaq board compliance after vacancies

Filed June 4, 2026 · Period ending May 29, 2026 · ~1 min read

4 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade TPST commission-free

Open an account, get a free stock.

Investing involves risk. Free stock terms apply.

Generated by AI · Jun 4, 2026 9:05 PM